Bullous pemphigoid — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Stop linagliptin and begin a high-potency topical corticosteroid regimen
The best answer is “Stop linagliptin and begin a high-potency topical corticosteroid regimen”. DPP-4 inhibitors are associated with bullous pemphigoid and the suspected drug should be withdrawn when feasible. High-potency topical corticosteroids are effective first-line treatment and can reduce systemic adverse effects when application is practical. Systemic therapy is reserved for situations where extent, response or logistics make topical treatment inadequate.
Reference: Updated S2 K Guideline for Bullous Pemphigoid: https://pubmed.ncbi.nlm.nih.gov/35848660/